Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase

The Antidepressant-Like Effect of Fish Oil: Possible Role of Ventral Hippocampal 5-HT1A Post-synaptic Receptor

(2014) Bruno Carabelli et al.   MOLECULAR NEUROBIOLOGY

Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin

(2013) Ronise M. Santiago et al.   BEHAVIOURAL BRAIN RESEARCH

Omega-3 deficiency and neurodegeneration in the substantia nigra: Involvement of increased nitric oxide production and reduced BDNF expression

(2013) Henriqueta Dias Cardoso et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Parkinson disease: from pathology to molecular disease mechanisms

(2013) David T. Dexter et al.   FREE RADICAL BIOLOGY AND MEDICINE

Reactive Oxygen Species and Inhibitors of Inflammatory Enzymes, NADPH Oxidase, and iNOS in Experimental Models of Parkinson’s Disease

(2012) Sushruta Koppula et al.   MEDIATORS OF INFLAMMATION

Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease

(2012) Louise M. Collins et al.   NEUROPHARMACOLOGY

n-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats

(2012) Ailing Ji et al.   NEUROTOXICOLOGY

Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation

(2012) Karsten H. Weylandt et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Impact of omega-3 fatty acids in Parkinson's disease

(2011) Mélanie Bousquet et al.   AGEING RESEARCH REVIEWS

The role of 5-HT1A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: A possible antidepressant mechanism

(2011) Aparecida Vines et al.   NEUROPHARMACOLOGY

Chronic ω-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol

(2010) Anete Curte Ferraz et al.   BEHAVIOURAL BRAIN RESEARCH

The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease.

(2010) Gamze Tanriover et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease

(2010) Lauren Broom et al.   FREE RADICAL BIOLOGY AND MEDICINE

Docosahexaenoic acid attenuates microglial activation and delays early retinal degeneration

(2009) Stefanie Ebert et al.   JOURNAL OF NEUROCHEMISTRY

Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease

(2009) Ana Marcia Delattre et al.   NEUROSCIENCE RESEARCH

A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway

(2008) Margarete Zanardo Gomes et al.   BRAIN RESEARCH

Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization

(2008) Véronique De Smedt-Peyrusse et al.   JOURNAL OF NEUROCHEMISTRY

Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease

(2008) M.T. Tadaiesky et al.   NEUROSCIENCE

Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: A stereological study

(2008) S. Omar Ahmad et al.   NEUROSCIENCE LETTERS

Differential astroglial activation in 6-hydroxydopamine models of Parkinson’s disease

(2008) Jeannette Henning et al.   NEUROSCIENCE RESEARCH

Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson’s disease

(2007) M. Bousquet et al.   FASEB JOURNAL